8:30 a.m. – 9:00 a.m.

 

Epidemiology and Evolution of Fertility Preservation in Women Undergoing Gonadotoxic Treatment
Emre Seli, MD
Yale School of Medicine, CT, USA

9:00 a.m. – 9:30 a.m.
 

Considering the Surroundings: Effects of Iatrogenic Exposures on the Ovarian Microenvironment
Francesca Duncan, PhD
Northwestern University, IL, USA

9:30 a.m. – 10:00 a.m.

10:00 a.m. – 10:30 a.m.

 

Ovarian Tissue Cryopreservation: State of the Art
Claus Yding Andersen, PhD
University of Copenhagen, Denmark

10:30 a.m. – 11:00 a.m.

 

Making a Baby from a Human Primordial Follicle: Where Do We Stand
Francesca Duncan, PhD
Northwestern University, IL, USA

11:00 a.m. – 11:30 a.m.

 

Towards an Artificial Ovary: Grafting Preantral Follicles on Decellularized Human Ovarian Tissue
Stine Gry Kristensen, PhD
University of Copenhagen, Denmark

11:30 a.m. – 12:00 p.m.
 

Social Egg Freezing
Juan Garcia-Velasco, MD, PhD
IVI RMA-Madrid / Rey Juan Carlos University, Madrid, Spain

12:00 p.m. – 1:30 p.m.

LUNCH

1:30 p.m. – 2:00 p.m.

 

Fertility Preservation in Women with Endometriosis
Pinar Kodaman, MD
Yale School of Medicine, CT, USA

2:00 p.m. – 2:30 p.m.

 

Long Term Outcomes in Cancer Patients Who Do and Do Not Pursue Fertility Preservation
Mary Ellen Pavone, MD
Northwestern University, IL, USA

2:30 p.m. – 3:00 p.m.
 

Fertility Preservation in Transgender Populations
Molly Moravek, MD
University of Michigan, MI, USA

3:00 p.m. – 3:30 p.m.
 

Fertility Preservation in Prepubertal Girls: Selecting the Right Patient for Ovarian Tissue Cryopreservation
Hamish Wallace, MD, PhD
University of Edinburgh, United Kingdom

3:30 p.m. – 4:00 p.m.

BREAK

4:00 p.m. – 4:30 p.m.
 

LH for Decreasing Follicle Loss in Women Receiving Gonadotoxic Treatment
Sonia Herraiz, PhD
Fundación IVI, Valencia, Spain

4:30 p.m. – 5:00 p.m.
 

The Role of AMH/MIS in the Ovary: Implications for Fertility and its Preservation
David Pepin, PhD
Massachusetts General Hospital, Harvard Medical School, MA, USA